Exact Mass: 545.275039
Exact Mass Matches: 545.275039
Found 320 metabolites which its exact mass value is equals to given mass value 545.275039
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a sulfated bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). As a bile acid sulfate, N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is typically found in urine. These conjugates are formed as a part of detoxification of endogenous and exogenous components in the body (PMID:3584362). [HMDB] N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a sulfated bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). As a bile acid sulfate, N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is typically found in urine. These conjugates are formed as a part of detoxification of endogenous and exogenous components in the body (PMID:3584362).
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895) [HMDB] N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895).
Glycocholic acid 3-sulfate
C26H43NO9S (545.2658388000001)
17-Aminogeldanamycin
Phe Ser His Arg
N-[(3a,5b,7a,12a)-7,12-Dihydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]glycine
C26H43NO9S (545.2658388000001)
BA-148-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Ala His Arg Tyr
Ala His Tyr Arg
Ala Asn Arg Trp
Ala Asn Trp Arg
Ala Arg His Tyr
Ala Arg Asn Trp
Ala Arg Trp Asn
Ala Arg Tyr His
Ala Trp Asn Arg
Ala Trp Arg Asn
Ala Tyr His Arg
Ala Tyr Arg His
Asp Ile Ile Trp
Asp Ile Leu Trp
Asp Ile Trp Ile
Asp Ile Trp Leu
Asp Leu Ile Trp
Asp Leu Leu Trp
Asp Leu Trp Ile
Asp Leu Trp Leu
Asp Trp Ile Ile
Asp Trp Ile Leu
Asp Trp Leu Ile
Asp Trp Leu Leu
Glu Glu Ile Arg
Glu Glu Leu Arg
Glu Glu Arg Ile
Glu Glu Arg Leu
Glu Ile Glu Arg
Glu Ile Arg Glu
Glu Ile Val Trp
Glu Ile Trp Val
Glu Leu Glu Arg
Glu Leu Arg Glu
Glu Leu Val Trp
Glu Leu Trp Val
Glu Arg Glu Ile
Glu Arg Glu Leu
Glu Arg Ile Glu
Glu Arg Leu Glu
Glu Val Ile Trp
Glu Val Leu Trp
Glu Val Trp Ile
Glu Val Trp Leu
Glu Trp Ile Val
Glu Trp Leu Val
Glu Trp Val Ile
Glu Trp Val Leu
Phe His Arg Ser
Phe His Ser Arg
Phe Arg His Ser
Phe Arg Ser His
Phe Ser Arg His
Gly Gln Arg Trp
Gly Gln Trp Arg
Gly Arg Gln Trp
Gly Arg Trp Gln
Gly Trp Gln Arg
Gly Trp Arg Gln
His Ala Arg Tyr
His Ala Tyr Arg
His Phe Arg Ser
His Phe Ser Arg
His His Pro Arg
His His Arg Pro
His Pro His Arg
His Pro Arg His
His Arg Ala Tyr
His Arg Phe Ser
His Arg His Pro
His Arg Pro His
His Arg Ser Phe
His Arg Tyr Ala
His Ser Phe Arg
His Ser Arg Phe
His Tyr Ala Arg
His Tyr Arg Ala
Ile Asp Ile Trp
Ile Asp Leu Trp
Ile Asp Trp Ile
Ile Asp Trp Leu
Ile Glu Glu Arg
Ile Glu Arg Glu
Ile Glu Val Trp
Ile Glu Trp Val
Ile Ile Asp Trp
Ile Ile Trp Asp
Ile Leu Asp Trp
Ile Leu Trp Asp
Ile Met Pro Trp
Ile Met Trp Pro
Ile Pro Met Trp
Ile Pro Trp Met
Ile Arg Glu Glu
Ile Val Glu Trp
Ile Val Trp Glu
Ile Trp Asp Ile
Ile Trp Asp Leu
Ile Trp Glu Val
Ile Trp Ile Asp
Ile Trp Leu Asp
Ile Trp Met Pro
Ile Trp Pro Met
Ile Trp Val Glu
Leu Asp Ile Trp
Leu Asp Leu Trp
Leu Asp Trp Ile
Leu Asp Trp Leu
Leu Glu Glu Arg
Leu Glu Arg Glu
Leu Glu Val Trp
Leu Glu Trp Val
Leu Ile Asp Trp
Leu Ile Trp Asp
Leu Leu Asp Trp
Leu Leu Trp Asp
Leu Met Pro Trp
Leu Met Trp Pro
Leu Pro Met Trp
Leu Pro Trp Met
Leu Arg Glu Glu
Leu Val Glu Trp
Leu Val Trp Glu
Leu Trp Asp Ile
Leu Trp Asp Leu
Leu Trp Glu Val
Leu Trp Ile Asp
Leu Trp Leu Asp
Leu Trp Met Pro
Leu Trp Pro Met
Leu Trp Val Glu
Met Ile Pro Trp
Met Ile Trp Pro
Met Leu Pro Trp
Met Leu Trp Pro
Met Pro Ile Trp
Met Pro Leu Trp
Met Pro Trp Ile
Met Pro Trp Leu
Met Trp Ile Pro
Met Trp Leu Pro
Met Trp Pro Ile
Met Trp Pro Leu
Asn Ala Arg Trp
Asn Ala Trp Arg
Asn Arg Ala Trp
Asn Arg Trp Ala
Asn Trp Ala Arg
Asn Trp Arg Ala
Pro His His Arg
Pro His Arg His
Pro Ile Met Trp
Pro Ile Trp Met
Pro Leu Met Trp
Pro Leu Trp Met
Pro Met Ile Trp
Pro Met Leu Trp
Pro Met Trp Ile
Pro Met Trp Leu
Pro Arg His His
Pro Trp Ile Met
Pro Trp Leu Met
Pro Trp Met Ile
Pro Trp Met Leu
Gln Gly Arg Trp
Gln Gly Trp Arg
Gln Arg Gly Trp
Gln Arg Trp Gly
Gln Trp Gly Arg
Gln Trp Arg Gly
Arg Ala His Tyr
Arg Ala Asn Trp
Arg Ala Trp Asn
Arg Ala Tyr His
Arg Glu Glu Ile
Arg Glu Glu Leu
Arg Glu Ile Glu
Arg Glu Leu Glu
Arg Phe His Ser
Arg Phe Ser His
Arg Gly Gln Trp
Arg Gly Trp Gln
Arg His Ala Tyr
Arg His Phe Ser
Arg His His Pro
Arg His Pro His
Arg His Ser Phe
Arg His Tyr Ala
Arg Ile Glu Glu
Arg Leu Glu Glu
Arg Asn Ala Trp
Arg Asn Trp Ala
Arg Pro His His
Arg Gln Gly Trp
Arg Gln Trp Gly
Arg Ser Phe His
Arg Ser His Phe
Arg Trp Ala Asn
Arg Trp Gly Gln
Arg Trp Asn Ala
Arg Trp Gln Gly
Arg Tyr Ala His
Arg Tyr His Ala
Ser Phe His Arg
Ser Phe Arg His
Ser His Phe Arg
Ser His Arg Phe
Ser Arg Phe His
Ser Arg His Phe
Val Glu Ile Trp
Val Glu Leu Trp
Val Glu Trp Ile
Val Glu Trp Leu
Val Ile Glu Trp
Val Ile Trp Glu
Val Leu Glu Trp
Val Leu Trp Glu
Val Trp Glu Ile
Val Trp Glu Leu
Val Trp Ile Glu
Val Trp Leu Glu
Trp Ala Asn Arg
Trp Ala Arg Asn
Trp Asp Ile Ile
Trp Asp Ile Leu
Trp Asp Leu Ile
Trp Asp Leu Leu
Trp Glu Ile Val
Trp Glu Leu Val
Trp Glu Val Ile
Trp Glu Val Leu
Trp Gly Gln Arg
Trp Gly Arg Gln
Trp Ile Asp Ile
Trp Ile Asp Leu
Trp Ile Glu Val
Trp Ile Ile Asp
Trp Ile Leu Asp
Trp Ile Met Pro
Trp Ile Pro Met
Trp Ile Val Glu
Trp Leu Asp Ile
Trp Leu Asp Leu
Trp Leu Glu Val
Trp Leu Ile Asp
Trp Leu Leu Asp
Trp Leu Met Pro
Trp Leu Pro Met
Trp Leu Val Glu
Trp Met Ile Pro
Trp Met Leu Pro
Trp Met Pro Ile
Trp Met Pro Leu
Trp Asn Ala Arg
Trp Asn Arg Ala
Trp Pro Ile Met
Trp Pro Leu Met
Trp Pro Met Ile
Trp Pro Met Leu
Trp Gln Gly Arg
Trp Gln Arg Gly
Trp Arg Ala Asn
Trp Arg Gly Gln
Trp Arg Asn Ala
Trp Arg Gln Gly
Trp Val Glu Ile
Trp Val Glu Leu
Trp Val Ile Glu
Trp Val Leu Glu
Tyr Ala His Arg
Tyr Ala Arg His
Tyr His Ala Arg
Tyr His Arg Ala
Tyr Arg Ala His
Tyr Arg His Ala
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfoxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfoxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
Colforsin daropate hydrochloride
C27H44ClNO8 (545.2755294000001)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D007155 - Immunologic Factors
17-Aminogeldanamycin
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
3alpha-Sulfooxy-7alpha,12alpha-dihydroxy-5beta-cholan-24-oyl-glycine
C26H43NO9S (545.2658388000001)
[(4E,6Z,10E)-19-amino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-[[(4R)-4-[(3R,5S,7R,10S,12S,13R,17R)-3,7-dihydroxy-10,13-dimethyl-12-sulooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
C26H43NO9S (545.2658388000001)